{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:46Z","timestamp":1793060026690,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022315","name":"Mason Medical Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jinf.2022.06.017","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T02:30:45Z","timestamp":1655951445000},"page":"327-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serology versus nucleic acid amplification to diagnose acute hepatitis E, United Kingdom, 2014\u201318"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8228-3758","authenticated-orcid":false,"given":"Jordan P.","family":"Skittrall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jinf.2022.06.017_bib0001","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2015.10.048","article-title":"Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2022.06.017_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2022.01.028","article-title":"Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: first report in Europe","author":"Rivero-Juarez","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jinf.2022.06.017_bib0003","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jinf.2022.06.017_bib0004","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijid.2020.12.081","article-title":"IgG antibody response demonstrates inverse correlation with viral load in Bangladeshi women with acute hepatitis E virus genotype 1 infection","volume":"104","author":"Sultana","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2022.06.017_bib0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcv.2009.01.005","article-title":"Indigenous hepatitis E virus infection in England: more common than it seems","volume":"44","author":"Ijaz","year":"2009","journal-title":"J Clin Virol"},{"issue":"9956","key":"10.1016\/j.jinf.2022.06.017_bib0006","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"issue":"9744","key":"10.1016\/j.jinf.2022.06.017_bib0007","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jinf.2022.06.017_bib0008","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/21645515.2015.1008870","article-title":"The development of a recombinant hepatitis E vaccine HEV 239","volume":"11","author":"Li","year":"2015","journal-title":"Human Vaccines Immunother"},{"issue":"7","key":"10.1016\/j.jinf.2022.06.017_bib0009","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jvh.13285","article-title":"Unexpected long-lasting anti-HEV IgM positivity: is HEV antigen a better serological marker for hepatitis E infection diagnosis?","volume":"27","author":"Riveiro-Barciela","year":"2020","journal-title":"J Viral Hepat"},{"issue":"10","key":"10.1016\/j.jinf.2022.06.017_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0013560","article-title":"Profile of acute infectious markers in sporadic hepatitis E","volume":"5","author":"Huang","year":"2010","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jinf.2022.06.017_bib0011","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcv.2009.05.022","article-title":"Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E","volume":"45","author":"Fogeda","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jinf.2022.06.017_bib0012","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jmv.23827","article-title":"Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection","volume":"86","author":"Hyams","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.jinf.2022.06.017_bib0013","unstructured":"Public Health England. UK Standards for Microbiology Investigations: screening and monitoring for hepatitis E infection. Available at https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/755911\/V_53i1.pdf. 2018. [cited 2022 May 20]."},{"issue":"6","key":"10.1016\/j.jinf.2022.06.017_bib0014","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"Clinical practice guidelines on hepatitis E virus infection","volume":"68","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2022.06.017_bib0015","unstructured":"European Centre for Disease Prevention and Control. Options for national testing and surveillance for hepatitis E virus in the EU\/EEA \u2013 Operational guidance. Available at https:\/\/www.ecdc.europa.eu\/en\/publications-data\/options-national-testing-and-surveillance-hepatitis-e-virus-eueea-operational. 2019. [cited 2022 May 20]."},{"key":"10.1016\/j.jinf.2022.06.017_bib0016","unstructured":"World Health Organization (WHO). Hepatitis E. Available at https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-e. 2021. [cited 2022 May 20]."},{"issue":"1","key":"10.1016\/j.jinf.2022.06.017_bib0017","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcv.2010.02.004","article-title":"First case of genotype 4 human hepatitis E virus infection acquired in India","volume":"48","author":"Rolfe","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jinf.2022.06.017_bib0018","unstructured":"R Core Team. R: a Language and Environment for Statistical Computing. Available at https:\/\/www.r-project.org\/. 2015. [cited 2022 May 20]."},{"issue":"15","key":"10.1016\/j.jinf.2022.06.017_bib0019","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/bioinformatics\/btv153","article-title":"PRROC: computing and visualizing Precision-recall and receiver operating characteristic curves in R","volume":"31","author":"Grau","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jinf.2022.06.017_bib0020","unstructured":"Wolfram Research Inc. Mathematica, Version 12.1. Champaign, IL; 2020."},{"issue":"2","key":"10.1016\/j.jinf.2022.06.017_bib0021","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/pathogens9020137","article-title":"Comprehensive evaluation of hepatitis E serology and molecular testing in a large cohort","volume":"9","author":"Anastasiou","year":"2020","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.jinf.2022.06.017_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00382-21","article-title":"Limited value of single sampling for IgM antibody determination as a diagnostic approach for acute hepatitis E virus infection","volume":"9","author":"Rivero-Juarez","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"5","key":"10.1016\/j.jinf.2022.06.017_bib0023","first-page":"299","article-title":"The standardization of diagnostic of hepatitis E","volume":"61","author":"Diarrassouba","year":"2016","journal-title":"Klin Lab Diagn (Russian Clinical Laboratory Diagnostics)"},{"issue":"3","key":"10.1016\/j.jinf.2022.06.017_bib0024","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/JCM.01853-14","article-title":"A valuable antigen detection method for diagnosis of acute hepatitis E","volume":"53","author":"Wen","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2022.06.017_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1743-422X-7-213","article-title":"Dynamics of HEV viremia, fecal shedding and its relationship with transaminases and antibody response in patients with sporadic acute hepatitis E","volume":"7","author":"Chandra","year":"2010","journal-title":"Virol J"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322003735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322003735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:34:24Z","timestamp":1759008864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445322003735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0163445322003735"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2022.06.017","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serology versus nucleic acid amplification to diagnose acute hepatitis E, United Kingdom, 2014\u201318","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2022.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}